David Einhorn
Greenlight Capital
David Einhorn COVIDIEN LTD stake
total: 357
Greenlight Capital F113PS trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2014 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q1
According to 2026 Q2 report, David Einhorn doesn't hold any COVIDIEN LTD (F113PS) shares. To date, the estimated cost basis is nearly $102.28 for "buy" trades and estimated average "sell" price is $102.28. Greenlight Capital first purchased F113PS in 2014 Q4, initially acquiring 851,341 shares. Since the initial investment in COVIDIEN LTD (F113PS), Greenlight Capital has made 1 more transaction.
When did David Einhorn sell COVIDIEN LTD (F113PS)?
David Einhorn sold off the entire COVIDIEN LTD (F113PS) position in 2015 Q1.
When did David Einhorn buy COVIDIEN LTD (F113PS)?
David Einhorn first invested in COVIDIEN LTD (F113PS) in 2014 Q4 at the reported quarter-end price of $102.28 per share.
What's the cost basis of Greenlight Capital's F113PS stake?
The estimated cost basis for COVIDIEN LTD (F113PS) stake is around $102.28 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $102.28
- Weighted AVG sell price:
- $102.28
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.